Dr. Vasu Divi, MD
Facial Plastic Surgery (Otolaryngology/Facial Plastic Surgery Physician)
300 Pasteur Dr
Stanford, CA 94305
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Michigan Medical School (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 180
Licensed in California since 2012, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: University of Michigan Medical School
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otolaryngology/Facial Plastic Surgery Physician primary
CA license A121464 (first issued 2012; current) -
Otolaryngology Physician
MI license 4301083303 -
Student in an Organized Health Care Education/Training Program
MI license 4301083303
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Stanford Health Care Stanford, CA
- Stanford Health Care Tri-Valley Pleasanton, CA
Medical groups
- Stanford Health Care (3,122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 180
- Services billed
- 519
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 111 | 85 |
| New patient office or other outpatient visit, 45-59 minutes | 42 | 42 |
| Removal of lymph nodes, muscle, and tissue of neck | 26 | 26 |
| New patient office or other outpatient visit, 60-74 minutes | 17 | 17 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 16 | 16 |
| Punch biopsy, first skin growth | 15 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 18 payments worth $20,705 in total to this clinician.
| Regeneron Healthcare Solutions, Inc. | $18,774 |
|---|---|
| Ethicon US, LLC | $1,931 |
| Consulting Fee | $18,155 |
|---|---|
| Travel and Lodging | $2,199 |
| Food and Beverage | $351 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $7,488 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $6,656 |
| Ethicon US, LLC Nov 13, 2025 | Consulting Fee VICRYL · Sutures | $1,931 |
| Regeneron Healthcare Solutions, Inc. Jan 14, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $1,003 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $832 |
| Regeneron Healthcare Solutions, Inc. May 30, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $832 |
| Regeneron Healthcare Solutions, Inc. Feb 26, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $495 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $416 |
| Regeneron Healthcare Solutions, Inc. Feb 18, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $253 |
| Regeneron Healthcare Solutions, Inc. Feb 18, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $161 |
All 13 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Ethicon US, LLC Nov 13, 2025 | Consulting Fee VICRYL · Sutures | $1,931 |
| Regeneron Healthcare Solutions, Inc. May 30, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $832 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $7,488 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $6,656 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $832 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $64.54 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $63.64 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Consulting Fee LIBTAYO · ONCOLOGY | $416 |
| Regeneron Healthcare Solutions, Inc. Feb 26, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $495 |
| Regeneron Healthcare Solutions, Inc. Feb 18, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $253 |
| Regeneron Healthcare Solutions, Inc. Feb 18, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $161 |
| Regeneron Healthcare Solutions, Inc. Jan 14, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $1,003 |
| Regeneron Healthcare Solutions, Inc. Jan 14, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to MIAMI, FL · in-kind | $160 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $142,833 in research payments for these studies, mostly to the institutions running them.
- Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT03969004 - Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals, Inc. · Completed · NCT04154943
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.